Massive study tracks real-world results of cystic fibrosis drug combination
NCT ID NCT03475381
Summary
This study followed 852 cystic fibrosis patients in France for one year to see how well the Orkambi drug combination works in everyday treatment. Researchers tracked whether patients continued taking the medication, monitored side effects, and measured lung function and overall health. The goal was to understand the real-world safety and effectiveness of this treatment outside of controlled clinical trials.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Adult CF center, Service de Pneumologie, Cochin Hospital
Paris, Paris, 75006, France
Conditions
Explore the condition pages connected to this study.